Jaguar Health, Inc. financial data

Symbol
JAGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Pine Street Suite 400, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Jaguar Animal Health, Inc. (to 7/31/2017)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % +112%
Quick Ratio 57 % +119%
Return On Equity -411 % +63.6%
Return On Assets -67 % +21.7%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 9.9M USD -60.4%
Weighted Average Number of Shares Outstanding, Basic 2.35M shares +700%
Weighted Average Number of Shares Outstanding, Diluted 2.35M shares +700%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.06M USD +5.86%
Research and Development Expense 17.5M USD -9.29%
Selling and Marketing Expense 5.97M USD -18.4%
General and Administrative Expense 16M USD -3.56%
Costs and Expenses 41.9M USD -7.18%
Operating Income (Loss) -31.8M USD +6.95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -36.2M USD +20.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -35.7M USD +19.8%
Earnings Per Share, Basic 37.9 USD/shares +90.2%
Earnings Per Share, Diluted 37.9 USD/shares +90.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16M USD +86%
Accounts Receivable, after Allowance for Credit Loss, Current 1.3M USD -7.02%
Inventory, Net 9.56M USD +15.6%
Assets, Current 40.1M USD +42.1%
Property, Plant and Equipment, Net 488K USD -7.22%
Operating Lease, Right-of-Use Asset 1.18M USD +24.4%
Intangible Assets, Net (Excluding Goodwill) 19.4M USD -9.58%
Assets 61.5M USD +17.8%
Accounts Payable, Current 4.09M USD -12.2%
Accrued Liabilities, Current 3.34M USD -66.7%
Contract with Customer, Liability, Current 170K USD
Liabilities, Current 19.1M USD -34%
Contract with Customer, Liability, Noncurrent 638K USD
Operating Lease, Liability, Noncurrent 812K USD +64%
Liabilities 42.4M USD -8.52%
Accumulated Other Comprehensive Income (Loss), Net of Tax -542K USD +25%
Retained Earnings (Accumulated Deficit) -327M USD -12.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.6M USD +184%
Liabilities and Equity 61.5M USD +17.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.05M USD +29.1%
Net Cash Provided by (Used in) Financing Activities 12.3M USD -34.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares, Issued 25.9M shares -20.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.2M USD -41.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16M USD +86%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD +50%
Deferred Tax Assets, Valuation Allowance 56.2M USD +97.6%
Deferred Tax Assets, Gross 57.6M USD +98.3%
Operating Lease, Liability 1.23M USD +21.6%
Payments to Acquire Property, Plant, and Equipment 0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -35.5M USD +21.4%
Lessee, Operating Lease, Liability, to be Paid 1.95M USD +69.1%
Property, Plant and Equipment, Gross 977K USD +1.67%
Operating Lease, Liability, Current 416K USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 243K USD +263%
Lessee, Operating Lease, Liability, to be Paid, Year One 346K USD -21%
Operating Lease, Weighted Average Discount Rate, Percent 0.2 pure +17.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 722K USD +405%
Lessee, Operating Lease, Liability, to be Paid, Year Three 236K USD +1715%
Deferred Tax Assets, Operating Loss Carryforwards 51.9M USD +109%
Preferred Stock, Shares Issued 99 shares -59.1%
Preferred Stock, Shares Authorized 10M shares +123%
Unrecognized Tax Benefits 77K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 243K USD
Operating Lease, Payments 336K USD +534%
Preferred Stock, Shares Outstanding 99 shares -59.1%
Amortization of Intangible Assets 1.95M USD +0.57%
Depreciation, Depletion and Amortization 501K USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 1.41M USD +132%
Share-based Payment Arrangement, Expense 383K USD -26.1%
Interest Expense 1.25M USD -89.2%